Detection of SARs-CoV-2 in wastewater using the existing environmental surveillance network: A potential supplementary system for monitoring COVID-19 transmission.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 06 08 2020
accepted: 19 03 2021
entrez: 29 6 2021
pubmed: 30 6 2021
medline: 13 7 2021
Statut: epublish

Résumé

The ongoing COVID-19 pandemic is caused by SARs-CoV-2. The virus is transmitted from person to person through droplet infections i.e. when infected person is in close contact with another person. In January 2020, first report of detection of SARS-CoV-2 in faeces, has made it clear that human wastewater might contain this virus. This may illustrate the probability of environmentally facilitated transmission, mainly the sewage, however, environmental conditions that could facilitate faecal oral transmission is not yet clear. We used existing Pakistan polio environment surveillance network to investigate presence of SARs-CoV-2 using three commercially available kits and E-Gene detection published assay for surety and confirmatory of positivity. A Two-phase separation method is used for sample clarification and concentration. An additional high-speed centrifugation (14000Xg for 30 min) step was introduced, prior RNA extraction, to increase viral RNA yield resulting a decrease in Cq value. A total of 78 wastewater samples collected from 38 districts across Pakistan, 74 wastewater samples from existing polio environment surveillance sites, 3 from drains of COVID-19 infected areas and 1 from COVID 19 quarantine center drainage, were tested for presence of SARs-CoV-2. 21 wastewater samples (27%) from 13 districts turned to be positive on RT-qPCR. SARs-COV-2 RNA positive samples from areas with COVID 19 patients and quarantine center strengthen the findings and use of wastewater surveillance in future. Furthermore, sequence data of partial ORF 1a generated from COVID 19 patient quarantine center drainage sample also reinforce our findings that SARs-CoV-2 can be detected in wastewater. This study finding indicates that SARs-CoV-2 detection through wastewater surveillance has an epidemiologic potential that can be used as supplementary system to monitor viral tracking and circulation in cities with lower COVID-19 testing capacity or heavily populated areas where door-to-door tracing may not be possible. However, attention is needed on virus concentration and detection assay to increase the sensitivity. Development of highly sensitive assay will be an indicator for virus monitoring and to provide early warning signs.

Identifiants

pubmed: 34185787
doi: 10.1371/journal.pone.0249568
pii: PONE-D-20-24543
pmc: PMC8241060
doi:

Substances chimiques

ORF1ab polyprotein, SARS-CoV-2 0
Polyproteins 0
RNA, Viral 0
Viral Proteins 0
Waste Water 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0249568

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Lancet. 2003 May 24;361(9371):1767-72
pubmed: 12781535
Jpn J Infect Dis. 2020 Jul 22;73(4):304-307
pubmed: 32074516
Environ Sci Technol. 2020 Apr 7;54(7):3730-3732
pubmed: 32202420
Lancet. 2004 May 22;363(9422):1699-700
pubmed: 15158632
Water Res. 2009 Apr;43(7):1893-8
pubmed: 19246070
Infect Dis Poverty. 2020 Mar 17;9(1):29
pubmed: 32183901
PLoS One. 2018 Dec 28;13(12):e0208336
pubmed: 30592720
Sci Total Environ. 2020 Aug 1;728:138764
pubmed: 32387778
Germs. 2019 Mar 01;9(1):35-42
pubmed: 31119115
Postgrad Med J. 2004 Jul;80(945):373-81
pubmed: 15254300
mSystems. 2020 Jul 21;5(4):
pubmed: 32694130
J Virol. 2013 Jul;87(14):7790-2
pubmed: 23678167

Auteurs

Salmaan Sharif (S)

National Institute of Health, Islamabad, Pakistan.

Aamer Ikram (A)

National Institute of Health, Islamabad, Pakistan.

Adnan Khurshid (A)

National Institute of Health, Islamabad, Pakistan.

Muhammad Salman (M)

National Institute of Health, Islamabad, Pakistan.

Nayab Mehmood (N)

National Institute of Health, Islamabad, Pakistan.

Yasir Arshad (Y)

National Institute of Health, Islamabad, Pakistan.

Jamal Ahmed (J)

World Health Organization, Islamabad, Pakistan.

Rana Muhammad Safdar (RM)

National Emergency Operations Centre for Polio Eradication, Islamabad, Pakistan.

Lubna Rehman (L)

National Institute of Health, Islamabad, Pakistan.

Ghulam Mujtaba (G)

National Institute of Health, Islamabad, Pakistan.

Jaffar Hussain (J)

National Institute of Health, Islamabad, Pakistan.

Johar Ali (J)

National Institute of Health, Islamabad, Pakistan.

Mehar Angez (M)

National Institute of Health, Islamabad, Pakistan.

Muhammad Masroor Alam (MM)

National Institute of Health, Islamabad, Pakistan.

Ribqa Akthar (R)

National Institute of Health, Islamabad, Pakistan.

Muhammad Wasif Malik (M)

National Institute of Health, Islamabad, Pakistan.

Mirza Zeeshan Iqbal Baig (MZ)

National Institute of Health, Islamabad, Pakistan.

Muhammad Suleman Rana (M)

National Institute of Health, Islamabad, Pakistan.

Muhammad Usman (M)

National Institute of Health, Islamabad, Pakistan.

Muhammad Qaisar Ali (M)

National Institute of Health, Islamabad, Pakistan.

Abdul Ahad (A)

National Institute of Health, Islamabad, Pakistan.

Nazish Badar (N)

National Institute of Health, Islamabad, Pakistan.

Massab Umair (M)

National Institute of Health, Islamabad, Pakistan.

Sana Tamim (S)

National Institute of Health, Islamabad, Pakistan.

Asiya Ashraf (A)

National Institute of Health, Islamabad, Pakistan.

Faheem Tahir (F)

National Institute of Health, Islamabad, Pakistan.

Nida Ali (N)

World Health Organization, Islamabad, Pakistan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH